XML 70 R55.htm IDEA: XBRL DOCUMENT v3.25.0.1
Commitments and Contingencies - Additional Information (Details) - USD ($)
 12 Months Ended
Feb. 21, 2024
Oct. 24, 2023
Sep. 28, 2023
Nov. 16, 2022
Dec. 23, 2016
Dec. 22, 2016
Nov. 20, 2014
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2021
Jul. 12, 2022
Commitments and Contingencies [Line Items]                      
Expenditures amount             $ 265,000        
Issued RSUs shares (in Shares)       48,140              
Aggregate value       $ 207,000              
Accounts payable               $ 99,000 $ 638,000    
Other long-term liabilities               265,000 0    
Accrued expenses               1,820,000 2,152,000    
Revenues               2,392,000 709,000    
License fee             5,000 0 0    
Cash payment             $ 50,000        
Agreement term             20 years        
Milestone payment               500,000      
Milestone fees payable               50,000 50,000    
Reimbursement               21,307      
Annual royalty fee               10,000      
Annual net sales percentage           1.00%          
Net sales of sub licensees percentage           10.00%          
Initial fee paid         $ 250,000            
License agreement amount         500,000            
Professional fees         $ 27,000            
License agreement term         20 years            
Incurred term         20 years            
Award amount               $ 3,000,000      
Settlement amount                     $ 1,400,000
Employee paid     $ 75,000                
Remaining costs     $ 35,000                
Supply Agreement [Member] | Secretome [Member]                      
Commitments and Contingencies [Line Items]                      
Agreement term 5 years                    
Initial start-up payment received $ 242,400                    
Technology transfer, documentation preparation, training, and testing costs 210,000                    
Project management fees 2,400                    
Suite reservation fee 30,000                    
Potential amount receivable for each product lot 55,000                    
Payments receivable for each additional product lot in excess of initial training run lots 30,000                    
Monthly manufacturing suite reservation fee 30,000                    
Hourly fee for project management services $ 240                    
Percentage markup on the value of materials compensated 20.00%                    
Outsourced testing fee per batch receivable $ 500                    
Monthly payment receivable for in process samples and vialed harvests for training 2,000                    
Standard fee receivable for product packing, handling and shipping 750                    
Increased fee for expedited or special hour service $ 1,500                    
Agreement termination description               Either party may terminate the agreement for cause and upon notice in the event of a material breach, within (i) 30 days of an uncured material breach that is not a payment default or (ii) 10 days for an uncured payment default. The Secretome Agreement further provides that either party may terminate the agreement at any time upon 90 days’ notice to the other party.      
Revenues               $ 1,000,000      
Nondisclosure Agreement [Member] | Secretome [Member]                      
Commitments and Contingencies [Line Items]                      
Agreement term   10 years                  
Longeveron [Member]                      
Commitments and Contingencies [Line Items]                      
Payments to UM               5,000      
UM Agreements [Member]                      
Commitments and Contingencies [Line Items]                      
Payments to UM               5,000      
Milestone fees payable               15,000 15,000    
UM License [Member]                      
Commitments and Contingencies [Line Items]                      
License fee                   $ 100,000  
Payments to UM               200,000      
first Phase 3 Clinical Trial [Member]                      
Commitments and Contingencies [Line Items]                      
Completion of trial             $ 150,000        
Biologics license [Member]                      
Commitments and Contingencies [Line Items]                      
License fee             $ 250,000        
Chief Science Officer [Member]                      
Commitments and Contingencies [Line Items]                      
Accounts payable                 100,000    
Other long-term liabilities               300,000      
Accrued expenses                 $ 100,000    
Chief Science Officer [Member] | Maximum [Member]                      
Commitments and Contingencies [Line Items]                      
Accrued expenses               $ 100,000      
Class A Common Stock [Member]                      
Commitments and Contingencies [Line Items]                      
Unregistered shares (in Shares)             110,387        
Series C Units [Member]                      
Commitments and Contingencies [Line Items]                      
Shares issued (in Shares)         10,000            
Company value amount         $ 250,000